510(k) · Cleared
ClearedSolo Micropump Insulin Delivery System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Medingo, Ltd. · LZG Pump, Infusion, Insulin
Cleared on Jan 25, 2010 as substantially equivalent to K090245 (Medingo, Ltd., 2009) and 2 other predicates after an 89-day review. Its family tree reaches back 2 generations to 2003.
- Decided
- Jan 25, 2010
- Review
- 89 days
- Class
- Class II
- Product code
- LZG
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 2 generations to K031373 (2003). 4 ancestors in all. No later device cites it as a predicate yet.
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K031373 | Ixl Diabetes Management System | Insulet Corp. | 2003 | — |
| −1 | K090245 | Solo Insulin Patch Pump | Medingo, Ltd. | 2009 | — |
| 0 (this device) | K093364 | Solo Micropump Insulin Delivery System | Medingo, Ltd. | 2010 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2005 | 1 | 0 |
| 2008 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LZG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LZG device
- #1 K253534 Pivot Insulin Delivery Systemscore 16.8 · 10 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K090245 | Solo Insulin Patch PumpSummary page 2…ry System - Page 5-2 Predicate Devices: > Medingo SoJoTM Insulin Patch Pump, insulin infusion pump, product code LZG, cleared for marketing under K090245 ("~SoloTm'~) > iXL Diabetes Management System (Insulet Corp.), product code LZG, cleared for marketing under K0… | 2009 |
| * | K031373 | Ixl Diabetes Management SystemSummary page 2…LZG, cleared for marketing under K090245 ("~SoloTm'~) > iXL Diabetes Management System (Insulet Corp.), product code LZG, cleared for marketing under K031373, K042792 Intended Use: The SoloT m MicroPump Insulin Delivery System is intended for the continuous delivery of insulin, at se… | 2003 |
| * | K042792 | Ixl-II Diabetes Management SystemSummary page 2…eared for marketing under K090245 ("~SoloTm'~) > iXL Diabetes Management System (Insulet Corp.), product code LZG, cleared for marketing under K031373, K042792 Intended Use: The SoloT m MicroPump Insulin Delivery System is intended for the continuous delivery of insulin, at set and var… | 2005 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 7 years and passes through 2 companies; a new generation was cleared every 5.6 years on median.
- None of the 4 ancestors has a recall.
How does its category compare?
All LZG devicesLZG Pump, Infusion, Insulin: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.
FDA decisions per year · LZG
2in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · LZG
116in 2016
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LZG
1in 2022
Class I (9 since 2007) Class II/III not classified
Adverse event reports per year · LZG
12,004in 2025
MAUDE reports naming product code LZG, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 3 | 112 | 1 | 5,110 |
| 2008 | 6 | 129 | 13 | 5,711 |
| 2009 | 2 | — | 2 | 9,471 |
| 2010 | 2 | — | 4 | 10,175 |
| 2011 | 4 | 189 | 2 | 12,858 |
| 2012 | 3 | 73 | 4 | 18,367 |
| 2013 | 2 | — | 3 (1) | 30,059 |
| 2014 | 4 | 123 | 2 (1) | 49,188 |
| 2015 | 1 | — | 2 (2) | 69,136 |
| 2016 | 4 | 116 | 0 | 56,581 |
| 2017 | 1 | — | 0 | 44,472 |
| 2018 | 1 | — | 3 (2) | 32,652 |
| 2019 | 2 | — | 5 | 29,027 |
| 2020 | 0 | — | 0 | 32,588 |
| 2021 | 1 | — | 0 | 31,522 |
| 2022 | 1 | — | 1 (1) | 28,225 |
| 2023 | 1 | — | 0 | 21,972 |
| 2024 | 2 | — | 0 | 18,228 |
| 2025 | 0 | — | 0 | 12,004 |
| 2026 | 2 | — | 2 (2) | — |
What is it indicated for?
The SoloTM MicroPump Insulin Delivery System is intended for the continuous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K093364 · printed Nov 6, 2026
Cite this page
510(k) Report. “K093364: Solo Micropump Insulin Delivery System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K093364
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026